Conference abstract · 28 Sep 2015
Conference abstractPublished 29 Sep 2014
Hematopoetic-stem-cell based therapy for HIV disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Our goals are to develop insight and understanding of the effect of deleting the chemokine receptor CCR5 in T cells important for HIV entry and its interplay with immune regulation in HIV, forming basis for a novel technology platform to cure HIV disease. A major innovation is the use of hematopoetic stem cell (HSC) transplantation of the cells resistant to HIV such as CCR5∆32 cells, which do not express CCR5 due to a deletion in the promoter. The mutation spontaneously occur in 4-15% of the European population (with frequency remarkably increased in North), confer resistance to HIV in homozygous individuals and could cure HIV disease based on the outcome of bone marrow engraftment in HIV patients with leukemia using a CCR5∆32 homozygous donor. However, patients receiving a bone marrow allotransplantation often suffer from graft- versus-host disease (GvHD), and for that reason HIV infection is not considered an indication, unless leukemia warrants transplantation. To advance this field, it is, however, vital with i) mapping of donors in bone marrow registries to identify CCR5∆32 donors for world-wide matching to HIV+ leukemic recipients; ii) to advance strategies to understand immune dysfunction and immune regulation in HIV and be able to offer suppression of GvHD and iii) to explore function of CCR5∆32 T cells and the possibility to manipulate CCR5 in stem cells moving towards future autotransplantion of CCR5 deleted hematopoetic stem cells. Our approach is to first screen Registries of Bone Marrow Donors in Norway and the Czech Republic and identify donors homozygous for ∆32 mutation. Secondly, in order to ameliorate GvHD, we intend to exploit mechanism of inhibition of interleukin-2 (IL-2) gene expression, which plays a crucial role in repression of CD4+T conventional cells (Tcons) by naturally occurring CD4+CD25+ T regulatory cells (nTregs). Transfer of cyclic AMP (cAMP) from nTregs to Tcons and/ or its receptor-mediated induction in adaptive Tregs underpins function of potent transcriptional repressor termed Inducible cAMP Early Repressor (ICER) leading to suppression of IL-2 synthesis thus reflecting potential suppressive function of T cells during GvHD. Further understanding of the mechanisms of immunological self-tolerance will also provide insights into how strong immune responses such as graft rejection could be restrained and engraftment of HIV resistant cells in HIV+ leukemic patients could be augmented.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2015
Hematopoietic Stem Cell-Based Therapy for HIV Disease: A Role for Regulatory T Cells
Conference abstract · 20 Mar 2017
Enhancing the protective effects of stem cell-based therapies with an anti-fibrotic drug in experimental chronic allergic airways disease
Conference abstract · 3 Nov 2015
Hematopoietic stem cell-based therapy for HIV disease: Prostaglandinmodulated transplantation
Conference abstract
Hematopoietic stem cell-based therapy for HIV disease: â??Berlinâ?? versus â??Essenâ?? patients
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Perspective · 10 Sep 2026
Cellular Pathways Involved in Mucosal Immunity and Protection Against Environmental Challenges
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Josef Bodor”

